Unknown

Dataset Information

0

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.


ABSTRACT:

Background

Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.

Methods

Two open-label, randomized trials were conducted in Nimba County, Liberia: i) the main tolerability trial with 1,000 Plasmodium falciparum malaria patients aged over five years (Study-T), and, ii) an efficacy trial with a secondary objective of collecting tolerability data among 300 children age six to 59 months (Study-E). In both studies patients were randomized to fixed-dose artesunate-amodiaquine (ASAQ Winthrop®) or artemether-lumefantrine (AL, Coartem®), respectively. Clinical- and laboratory-adverse events (AEs) were recorded until day 28.

Results

Study-T: most patients experienced at least one AE. Severe AEs were few, primarily asymptomatic blood system disorders or increased liver enzyme values. No treatment or study discontinuation occurred. Mild or moderate fatigue (39.8% vs 16.3%, p?ConclusionBoth ASAQ and AL were well tolerated in patients of all age groups. No unexpected AEs occurred. Certain mild or moderate AEs were more frequent in the ASAQ arm. Standardised safety surveillance should continue for all forms of ACT.

Trial registration

The protocols were registered with Current Controlled Trials, under the identifier numbers ISRCTN40020296, ISRCTN51688713, (http://www.controlled-trials.com).

SUBMITTER: Schramm B 

PROVIDER: S-EPMC3728046 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.

Schramm Birgit B   Valeh Parastou P   Baudin Elisabeth E   Mazinda Charles S CS   Smith Richard R   Pinoges Loretxu L   Sundaygar Timothy T   Zolia Yah M YM   Jones Joel J JJ   Comte Eric E   Bruneel Arnaud A   Branger Michel M   Jullien Vincent V   Carn Gwenaelle G   Kiechel Jean-René JR   Ashley Elizabeth A EA   Guérin Philippe J PJ  

Malaria journal 20130717


<h4>Background</h4>Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.<h4>Methods</h4>Two open-label, randomized trials were conducted in Nimba County, Liberia: i) the main tolerability trial with 1,000 Plasmodium falciparum malaria patients aged over five years (Study-T), and, ii) an efficacy trial with a secondary objective of collecting tolerability data among 300 children ag  ...[more]

Similar Datasets

| S-EPMC3728070 | biostudies-literature
| S-EPMC6591907 | biostudies-literature
| S-EPMC4249977 | biostudies-literature
| S-EPMC9044686 | biostudies-literature
| S-EPMC8565026 | biostudies-literature
| S-EPMC2430614 | biostudies-literature
| S-EPMC6355558 | biostudies-literature
| S-EPMC3171378 | biostudies-literature
| S-EPMC8487544 | biostudies-literature
| S-EPMC3413505 | biostudies-literature